Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120

AIDS Research and Human Retroviruses

Volumn 14, Issue 3, 1998, Pages 191-198

  Binley, James M ^a   Wyatt, Richard ^b,d   Desjardins, Elizabeth ^b,d   Kwong, Peter D ^c   Hendrickson, Wayne ^c   Moore, John P ^a   Sodroski, Joseph ^b,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; COMPETITIVE INHIBITION; DEGLYCOSYLATION; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; VIRUS NEUTRALIZATION; VIRUS RESISTANCE;

EID: 0032501955     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.191     Document Type: Article

References (37)

1. Moore JP and Ho DD: HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells. AIDS 1995;9(Suppl. A):S117-S136.
2. Kent KA and Robinson J: Antigenic determinants on HIV-1 envelope glycoproteins: A Dickens of a time with an Oligomer Twist. AIDS 1996;10(Suppl. A):S107-S114.
3. Fenouillet E, Gluckman JC, and Jones IM: Functions of HIV envelope glycans. Trends Biochem Sci 1994;19:65-70.
4. Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, and Wolf H: Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: Prediction of antigenic epitopes in conserved and variable domains. J Virol 1987;61:570-578.
5. Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks WP, Josephs SF, Gallo RC, and Wong-Staal F: Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986;45:637-648.
6. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, and Gregory TJ: Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990;265: 10373-10382.
7. Moore JP, Sattentau QJ, Wyatt R, and Sodroski J: Probing the structure of the surface glycoprotein gp120 of human immunodeficiency virus type 1 with a panel of monoclonal antibodies. J Virol 1994;68:469-484.
8. Decroly E, Comet B, Martin I, Ruysschaert J-M, and Vandenbranden M: Secondary structure of gp160 and gp120 envelope glycoproteins of human immunodeficiency virus type 1: A Fourier transform infrared spectroscopic study. J Virol 1993;67:3552-3560.
9. Moore JP, Willey RL, Lewis GK, Robinson J, and Sodroski J: Immunological evidence for interactions between the first, second and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J Virol 1994;68:6836-6847.
10. Gallaher WR, Ball JM, Garry RF, Martin-Amedec AM, and Montelaro RC: A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 1995; 11:191-202.
11. Thali M, Olshevsky U, Furman C, Gabuzda D, Posner M, and Sodroski J: Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J Virol 1991;65: 6188-6193.
12. Thali M, Furman C, Ho DD, Robinson J, Tilley S, Pinter A, and Sodroski J: Discontinuous, conserved neutralization epitopes overlapping the CD4 binding region of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol 1992;66: 5635-5641.
13. Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, and Sodroski J: Characterization of human immunodeficiency virus type 1 (HIV-1) gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993;67:3978-3988.
14. Roben P, Moore JP, Thali M, Sodroski J, Barbas CF III, and Burton DR: Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 showing differing ability to neutralize human immunodeficiency virus type 1. J Virol 1994;68:4821-4828.
15. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinvasan K, Sodroski J, Moore JP, and Katinger H: Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996;70:1100-1108.
16. Moore JP, Thali M, Jameson BA, Vignaux F, Lewis GK, Poon S-W, Fung MS, Sun NC, Charles M, Durda PJ, Åkerblom L, Wahren B, Ho DD, Sattentau QJ, and Sodroski J: Immunochemical analysis of human immunodeficiency virus type 1: Probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J Virol 1993;67:4785-4796.
17. Moore JP, Sattentau QJ, Yoshiyama H, Thali M, Charles M, Sullivan N, Poon S-W, Fung MS, Traincard F, Pinkus M, Robey G, Robinson JE, Ho DD, and Sodroski J: Probing the structure of the V2 domain of the human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: The human immune response to the V1 and V2 domains. J Virol 1993;67:6136-6151.
18. Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, and Sodroski J: Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 binding. J Virol 1990;64:5701-5707.
19. Moore JP and Sodroski J: Antibody cross-competition analysis of the human immunodeficiency virus type 1 exterior envelope glycoprotein. J Virol 1996;70:1863-1872.
20. Pollard S, Rosa MD, Rosa JJ, and Wiley DC: Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J 1992;11:585-591.
21. Wyatt R, Sullivan N, Thali M, Repke H, Ho D, Robinson J, Posner M, and Sodroski J: Characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J Virol 1993;67:4557-4565.
22. Jeffs SA, McKeating J, Lewis S, Craft H, Biran D, Stephens PE, and Brady RL: Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein. J Gen Virol 1996;77:1403-1410.
23. Wyatt R, Moore JP, Accola M, Desjardins E, Robinson J, and Sodroski J: Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995;69:5723-5733.
24. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine W, and Sodroski J: Functional regions of the envelope glycoproteins of human immunodeficiency virus type 1. Science 1987;237:1351-1355.
25. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardins E, Newman W, Gerard C, and Sodroski J: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (London) 1996;384:179-183.
26. Kwong, PD, et al.: Surface modification and conformation restriction in the crystallization of the HIV-1 gp120 envelope glycoprotein. In preparation (1997).
27. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, and Katinger H: Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996;70:1100-1108.
28. Roben P, Moore JP, Thali M, Sodroski J, Barbas CF, and Burton DR: Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J Virol 1994;68:4821-4828.
29. Moore JP, Yoshiyama H, Ho DD, Robinson JE, and Sodroski J: Antigenic variation in gp120s from molecular clones of HIV-1 LAI. AIDS Res Hum Retroviruses 1993;9:1179-1187.
30. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, and Moore JP: CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR5. Nature (London) 1996;384:184-186.
31. Benjouad A, Gluckman JC, Rochat H, Montagnier L, and Bahraoui E: Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol 1992;66:2473-2483.
32. Bolmstedt A, Sjolander S, Hansen JE, Akerblom L, Hemming A, Hu SL, Morein B, and Olofsson S: Influence of N-linked glycans in the V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J AIDS 1996;12:213-220.
33. Gram GJ, Hemming A, Bolmstedt A, Jansson B, Olofsson S, Åkerblom L, Neilsen JO, and Hansen JE: Identification of an N-linked glycan in the V1 loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch Virol 1994;139:253-261.
34. Back N, Smit L, DeJong JJ, Keulen W, Schutten M, Goudsmit J, and Tersmette M: An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 1994;199:431-438.
35. Schønning K, Jansson B, Olofsson S, Neilsen JO, and Hansen JE: Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology 1996;218:134-140.
36. Sjölander S, Bolmstedt A, Åkerblom L, Horal P, Olofsson S, Morein B, and Sjölander A: N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity. Virology 1996;215:124-133.
37. Botarelli P, Houlden BA, Haigwood NL, Servis C, Montagna D, and Abrignani S: N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J Immunol 1991; 147:3128-3132.